$SBFM: Sunshine Biopharma Launches eCommerce Store for Its

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
153
$SBFM: Sunshine Biopharma Launches eCommerce Store for Its Science-Based Nutritional Supplements

MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a leader in nutrition research and development today unveiled its new eCommerce website, Nutrition.SunshineBiopharma.com. The site boasts over 20 products ranging from essential amino acids and rich protein powders to balanced vitamins and crucial micronutrients. All of Sunshine Biopharma’s nutritional supplements are manufactured and tested in Canada under strict GMP conditions and Health Canada oversight. Some of the products listed on Nutrition.Sunshinebiopharma.com will continue to be available on Amazon.com and Amazon.ca.

Seekers of the highest quality, science-based nutritional products will enjoy the Nutrition.SunshineBiopharma.com experience where they can easily browse the items listed, place their order and checkout in a streamlined manner. Among the products featured on Nutrition.SunshineBiopharma.com is Essential 9™, a tablet containing all 9 essential amino acids that the human body cannot produce on its own. Essential 9™ was developed and formulated by Sunshine Biopharma, a pharmaceutical company that has the user’s optimum health in mind. Now more than ever, it is critical to maintain optimal health amidst the global pandemic. Among its many benefits, Essential 9™ can help boost the immune system and increase overall health. In addition to Essential 9™, Nutrition.SunshineBiopharma.com offers other health promoting supplements including balanced vitamins, individual amino acids, protein, and meal replacement products.

"In 2020, eCommerce sales in the US amounted to approximately $374 billion and are expected to reach $476 billion by 2024. We are thrilled to introduce Nutrition.Sunshinebiopharma.com, which allows customers to shop reliable, routinely tested nutritional supplements anytime," said Camille Sebaaly, CFO of Sunshine Biopharma. "Our site will feature a unique assortment of the nutritional products valued by everyone. We are excited for customers to enjoy our fun, interactive features and curations."

About Essential 9™

Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis. Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters. Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, chronic fatigue, weight gain, and weakened immune system. Sunshine Biopharma’s Essential-9™ provides a balanced formula of all 9 Essential Amino Acids in free-form, ready to be absorbed. Essential-9™ is suitable for everyone: Vegans, Seniors, Dieters, Athletes, and everyone looking to increase their health.

Safe Harbor Forward-Looking Statements

This press release may contain forward-looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new service lines noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations we will be providing services in, the impact of which cannot be predicted at this time.

For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
http://www.sunshinebiopharma.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ALS Research Gains Momentum as ACT for ALS Law Signed

Updated Category News Views 36

A Major Stride in ALS Advocacy Today's not your usual day at the office for the folks championing the fight against ALS. With the President putting pen to paper, the ACT for ALS Act just turned into law, sending ripples through the community. Let me tell ya, legislation like this doesn't float by on a cloud—it's the result of grit, sleepless nights, and a dash of...

Continue Reading
SportsMed Expands to 58 Clinics, New Opening in Jersey City

Updated Category News Views 33

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Continue Reading
Quarterhill's Q3 2026 Call Teases Insight into ITS Growth

Updated Category News Views 19

The clock's ticking down to November 10, and eyes are peeled for Quarterhill's Q3 financial debrief. Why the fuss? Well, they’ve made quite a name for themselves in the Intelligent Transportation System (ITS) scene, tossing AI into the mix to boot. If you’re playing in this space—or just sneaking a peek to see where tech’s steering us next—you might want to dial...

Continue Reading
Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 10

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 98

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
WhiteFiber: Expanding North Carolina Data Center Capacity

Updated Category News Views 20

WhiteFiber's Strategic Leap in North Carolina When a company starts throwing millions around, you better perk your ears up. WhiteFiber's $60 million plunge into North Carolina's dirt has filled their cart with two hefty data center projects. They're not messing around—just look at that cash down, with NASDAQ:WYFI betting big on these Yadkin County sites. Smart move or...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 68

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
FileInvite Transforms Complex Lending with Bold Platform Relaunch

Updated Category News Views 52

A New Era for Lending Documentation If you've been drumming your fingers waiting on loan paperwork to get sorted, FileInvite's latest move might just be the caffeine kick the lending world needs. Announced at the NAGGL Annual Conference, their souped-up platform has been redesigned as the beating heart of lending documentation. This isn't just a facelift folks—it's an...

Continue Reading
Tigo Energy Faces Class Action: Investor Implications

Updated Category News Views 46

Ah, here we go again, folks. Another day, another stock horror story. This time it’s Tigo Energy, Inc. (NASDAQ:TYGO) struggling under the microscope of a securities class action, care of the Law Offices of Howard G. Smith. If you’ve been keeping an eye on this one, buckle up—it's quite the mess. The Situation at Tigo Energy First off, let’s talk numbers. Tigo...

Continue Reading
Cerbo's AI Scribe Expands to Telehealth Success

Updated Category News Views 78

Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...

Continue Reading

Top 5 Most Recently Viewed Articles

AbbVie Reports Encouraging Findings from TEMPO-2 Trial

Updated Category News Views 248

AbbVie Reports Positive Results from the Phase 3 TEMPO-2 Trial AbbVie (NYSE: ABBV) has made significant strides in the treatment of Parkinson's disease with its investigational drug, tavapadon. Recent findings from the pivotal Phase 3 TEMPO-2 trial have brought forth encouraging news for those affected by this challenging condition. Tavapadon demonstrated a notable...

Continue Reading
Understanding Recent Trends in Honda Motor Co's Stock Interest

Updated Category News Views 101

Trends in Short Interest for Honda Motor Co Honda Motor Co's short percent of float has recently dropped by 8.57%, according to the latest reporting. Currently, there are 4.27 million shares sold short, which accounts for 0.32% of all available shares. Considering the trading volume, it would typically require around 4.71 days for traders to cover their short positions on...

Continue Reading
HMH Distributes Historic Artwork to Northeast Museums

Updated Category News Views 88

A Treasure Chest of Art Finds New Homes When it comes to donating art, HMH isn't just about flipping a few pages of history; they're turning whole chapters. HMH, with a legacy stretching back centuries in the heartland of Boston, decided to part ways with 20 pieces of iconic art, spreading cultural seeds across some prominent northeastern museums. These aren't just any...

Continue Reading
Kasm Technologies Unveils Major Update to Workspaces Platform

Updated Category News Views 369

Exciting New Features in Kasm Workspaces v1.16 Kasm Technologies has introduced significant upgrades with the launch of Kasm Workspaces v1.16, enhancing its remote workplace streaming platform. This version integrates Kubernetes support, a Managed Egress feature, and an RDP Gateway, ensuring a more robust and secure user experience. Improved Remote Work Capabilities With...

Continue Reading
GoldQuest Mining Corp. Joins OTCQX: A Milestone Achievement

Updated Category News Views 138

GoldQuest Mining Corp. Upgrades to OTCQX This significant upgrade allows GoldQuest Mining Corp. (OTC: GDQMF) to access a broader spectrum of U.S. investors and enhance its market presence. By transitioning from the Pink Limited Market to the OTCQX Best Market, the company is aligned with higher financial standards and corporate governance practices. CEO’s Insight on...

Continue Reading